Subscribe To
Intercept: huge potential upsides with binary catalyst unlocking
Due to what is seemingly a successful comeback, you can expect Intercept pharmaceuticals to potentially...
January 24, 2023, 5:50 am
Vht: you won't get defensive healthcare exposure here
Healthcare is considered a defensive sector and due to the brand name and cheap exposure, Vanguard's ETF prima-facie looks like a promising idea. Howe...
January 24, 2023, 5:28 am
Jim cramer says there's a buying opportunity in this pharmaceutical company
Cramer gave his take on why investors should consider picking up shares of Eli Lilly....
January 23, 2023, 7:55 pm
Novozymes: wonderful company, almost reasonable price
Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's pr...
January 23, 2023, 7:33 pm
Catalyst pharmaceuticals comments on fda’s announcement of its position on orphan drug exclusivity in light of the 11th circuit decision in catalyst pharmaceuticals, inc. v. becerra
Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE® CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) — Catalyst ...
January 23, 2023, 6:25 pm
Squarex pharmaceutical seeks ipo for development funding
Squarex pharmaceutical Corporation has filed to raise capital via a U.S. IPO. The firm is developing a ...
January 23, 2023, 2:33 pm
Bioasis technologies inc. announces termination of arrangement agreement with midatech pharma plc
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-...
January 23, 2023, 2:22 pm
22nd century group (xxii) announces filing of u.s. dmf (drug master file) for cbd api; new global sales, marketing and distribution agreement with transo-pharm for cannabinoid apis
Partnership Will Provide pharmaceutical Grade Cannabinoid Active Ingredients to the Largest ...
January 23, 2023, 2:20 pm
Matinas biopharma to provide corporate update and 2023 business outlook on january 30, 2023
Conference call and live audio webcast scheduled for Monday, January 30th at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas...
January 23, 2023, 12:00 pm
Concert (cnce) stock up 17% last week on sun pharma buyout offer
Concert pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun
January 23, 2023, 11:17 am
Wall street analysts think rocket pharmaceuticals (rckt) could surge 163.35%: read this before placing a bet
The mean of analysts' price targets for Rocket pharmaceuticals (RCKT) points to a 163.4% upside in the ...
January 23, 2023, 11:17 am
Gum turpentine oil market size worth usd 1,579.83 million by 2030, registering a cagr of 6.52% – report by market research future (mrfr)
Gum Turpentine Oil Market Research Report Information By Type (Wood Turpentine, Sulphate Turpentine, Fat Turpentine, Carbonization Turpentine) Applica...
January 23, 2023, 11:16 am
Respirerx pharmaceuticals strikes second amendment to its license agreement with the university of illinois
RespireRx pharmaceuticals (OTC:RSPI) Inc revealed that the company and the Board of Trustees of Univers...
January 23, 2023, 10:55 am
3 drug stocks with promising pipelines for 2023
The world of pharmaceutical progress happens incrementally and exponentially. That is, therapies are it...
January 23, 2023, 10:03 am
Pulmatrix to present data on pur1800 at the annual meeting of the american academy of allergy, asthma and immunology
LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceu...
January 23, 2023, 9:05 am
Takeda inks deal with hutchmed for up to $1.1 billion
Takeda pharmaceutical Co. Ltd. TAK, +0.43% 4502, +0.65% said Monday that it will acquire Hutchmed's HCM...
January 23, 2023, 8:31 am
Voyageur pharmaceuticals completes second and final closing of its private placement for gross proceeds of $1,019,953.53
Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has completed the second and final closing o...
January 23, 2023, 6:47 am
Hutchmed shares jump on us$1.13bn takeda deal
Shares in Hutchmed (China) Ltd jumped 6.5% after it announced a licensing deal with Takeda pharmaceutical...
January 23, 2023, 6:36 am
Retransmission: defence to present at the 9th annual immuno-oncology 360º summit in new-york february 7-10, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the...
January 23, 2023, 3:15 am
The glycolic acid market is projected to reach us$ 764.8 million by 2032, at a cagr of 5.3% says future market insights, inc.
Burgeoning Demand from Personal Care and pharmaceutical Industries to Steer Glycolic Acid Sales Past US...
January 23, 2023, 1:30 am